Hangzhou Jeci Biochem Technology Co., Ltd. is strategically located in Hangzhou, Zhejiang Province, the heart of China's pharmaceutical innovation hub. We are committed to the sales of active pharmaceutical ingredients (APIs), high-end pharmaceutical intermediates, nutritional products, and food additives.
Our core business integrates cooperative R&D, custom manufacturing, and comprehensive import-export services. As a leading Wholesale SGLT2 Inhibitors Manufacturer, we bridge the gap between advanced chemical synthesis and global healthcare needs.
Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors have revolutionized the treatment of Type 2 Diabetes and are increasingly recognized for their cardio-renal protective benefits. The global market for pharmaceutical materials like Dapagliflozin, Empagliflozin, and Canagliflozin is witnessing an unprecedented CAGR of over 8%.
With the expansion of indications for heart failure and chronic kidney disease, global pharmaceutical giants and regional formulation labs are searching for reliable Wholesale SGLT2 Inhibitors Manufacturers. The demand is shifting towards high-purity crystalline forms and sustainable synthesis routes that ensure both cost-efficiency and environmental compliance.
Our facility provides the essential building blocks for these life-saving medications, ensuring that every batch meets rigorous international standards, including ICH guidelines.
We work in-depth with new drug research institutes and multiple custom processing plants in China. This allows us to handle complex molecular syntheses, including advanced SGLT2 inhibitor intermediates.
We maintain long-term trade relations with India, Southeast Asia, South Korea, and Japan. Our services include product registration, consulting, and sales channel expansion for overseas partners in the Chinese market.
We provide factory quality management system certification consulting and batch processing for industrial-scale raw materials. Our production equipment is designed for high-volume efficiency.
Our chemical intermediates are not just powders; they are the foundation of modern therapy. From oncology to endocrinology, our products like Dacomitinib Powder and SGLT2 precursors serve vital roles:
SGLT2 inhibitors are being studied for use in personalized combination therapies. As a manufacturer, we are adapting our R&D to provide customized purity levels and particle distributions to meet specific therapeutic delivery systems.
The industry is moving towards "Zero Waste" manufacturing. Jeci Biochem is investing in enzymatic catalysis and continuous flow chemistry to reduce the environmental footprint of API production.
Post-pandemic, global buyers require "China+1" or highly stable Chinese partners. Our dual-channel domestic and international sales network ensures a steady supply of SGLT2 inhibitors and other critical anticancer drugs even during market fluctuations.
SJ medical
